摘要Objective: To study the correlation between the expression of transforming growth factor-β1 (TGF-β1), RhoA, SOX9 and renal interstitial fibrosis in rats with chronic kidney disease. Methods: Forty specific pathogen-free (SPF) male SD rats were randomly divided into study group and control group, with 20 cases in each group. The study group was given adenine suspension by gavage, while the control group was given the same amount of saline by gavage. Blood, urine and renal tissue specimens were collected from all rats at 3rd and 6th weeks after modeling. The kidney weight, kidney weight/body weight, renal function indexes, the expression of TGF-β1, RhoA and SOX9 mRNA in renal tissues, Masson staining and renal interstitial fibrosis score were compared between the two groups. Pearson correlation was used to analyze the relationship between the renal interstitial fibrosis score and the expression of TGF-β1, RhoA and SOX9 mRNA in renal tissues of rats with chronic kidney disease. Results: The kidney weight and kidney weight/body weight of rats in the study group were higher than those in the control group at 3rd and 6th weeks after modeling (P<0.05). The quantitative levels of creatinine, urea nitrogen and 24-hour urinary protein in the study group were higher than those in the control group at 3rd and 6th weeks after modeling (P<0.05). The expression levels of TGF-β1, RhoA and SOX9 mRNA in renal tissues of rats in the study group were higher than those in the control group at 3rd and 6th weeks after modeling(P<0.05). The renal interstitial fibrosis score in the study group was higher than that in the control group at 3rd and 6th weeks after modeling(P<0.05). Pearson correlation analysis confirmed that the renal interstitial fibrosis score in rats with chronic kidney disease was positively correlated with the expression of TGF-β1, RhoA and SOX9 mRNA in renal tissues(P<0.05). Conclusion: The expression of TGF-β1, RhoA and SOX9 was abnormally high in rats with chronic kidney disease and was closely related to renal interstitial fibrosis, which may play a promoting role in the process of renal interstitial fibrosis.
Abstract：Objective: To study the correlation between the expression of transforming growth factor-β1 (TGF-β1), RhoA, SOX9 and renal interstitial fibrosis in rats with chronic kidney disease. Methods: Forty specific pathogen-free (SPF) male SD rats were randomly divided into study group and control group, with 20 cases in each group. The study group was given adenine suspension by gavage, while the control group was given the same amount of saline by gavage. Blood, urine and renal tissue specimens were collected from all rats at 3rd and 6th weeks after modeling. The kidney weight, kidney weight/body weight, renal function indexes, the expression of TGF-β1, RhoA and SOX9 mRNA in renal tissues, Masson staining and renal interstitial fibrosis score were compared between the two groups. Pearson correlation was used to analyze the relationship between the renal interstitial fibrosis score and the expression of TGF-β1, RhoA and SOX9 mRNA in renal tissues of rats with chronic kidney disease. Results: The kidney weight and kidney weight/body weight of rats in the study group were higher than those in the control group at 3rd and 6th weeks after modeling (P<0.05). The quantitative levels of creatinine, urea nitrogen and 24-hour urinary protein in the study group were higher than those in the control group at 3rd and 6th weeks after modeling (P<0.05). The expression levels of TGF-β1, RhoA and SOX9 mRNA in renal tissues of rats in the study group were higher than those in the control group at 3rd and 6th weeks after modeling(P<0.05). The renal interstitial fibrosis score in the study group was higher than that in the control group at 3rd and 6th weeks after modeling(P<0.05). Pearson correlation analysis confirmed that the renal interstitial fibrosis score in rats with chronic kidney disease was positively correlated with the expression of TGF-β1, RhoA and SOX9 mRNA in renal tissues(P<0.05). Conclusion: The expression of TGF-β1, RhoA and SOX9 was abnormally high in rats with chronic kidney disease and was closely related to renal interstitial fibrosis, which may play a promoting role in the process of renal interstitial fibrosis.
GUO Chun-hua, LI Hua-qing, LIN Zheng, QIU Zhao-wen, DENG Jin-xiu, ZHANG Qiu-xia, LIN Yong. Correlation between the Expression of TGF-β1, Rhoa, SOX9 and Renal Interstitial Fibrosis in Rats with Chronic Kidney Disease[J]. 中国生物医学工程学报(英文版）, 2023, 32(2): 65-72.
GUO Chun-hua, LI Hua-qing, LIN Zheng, QIU Zhao-wen, DENG Jin-xiu, ZHANG Qiu-xia, LIN Yong. Correlation between the Expression of TGF-β1, Rhoa, SOX9 and Renal Interstitial Fibrosis in Rats with Chronic Kidney Disease. Chinese Journal of Biomedical Engineering, 2023, 32(2): 65-72.
[1] Sellmayr M, Hernandez Petzsche MR, Ma Q, et al.Only hyperuricemia with crystalluria, but not asymptomatic hyperuricemia, drives progression of chronic kidney disease[J]. J Am Soc Nephrol,2020,31(12):2773-2792. [2] Nagavally RR, Sunilkumar S, Akhtar M, et al.Chrysin ameliorates cyclosporine-A-induced renal fibrosis by inhibiting TGF-β1-induced epithelial-mesenchymal transition[J].Int J Mol Sci,2021,22(19):10252. [3] Shi Z, Wang Q, Zhang Y, et al.Extracellular vesicles produced by bone marrow mesenchymal stem cells attenuate renal fibrosis, in part by inhibiting the RhoA/ROCK pathway, in a UUO rat model[J].Stem Cell Res Ther,2020,11(1):253. [4] Shi HH, Zhang LY, Chen LP, et al.EPA-enriched phospholipids alleviate renal interstitial fibrosis in spontaneously hypertensive rats by regulating TGF-β signaling pathways[J].Mar Drugs,2022,20(2):152. [5] Chen Z, Chen J, Chen H,et al.Evaluation of renal fibrosis in patients with chronic kidney disease by shear wave elastography: a comparative analysis with pathological findings[J].Abdom Radiol (NY),2022,47(2):738-745. [6] Sun H, Li X, Chen X,et al.Drp1 activates ROS/HIF-1α/EZH2 and triggers mitochondrial fragmentation to deteriorate hypercalcemia-associated neuronal injury in mouse model of chronic kidney disease[J].J Neuroinflammation,2022,19(1):213. [7] Peng X, Su H, Liang D, et al.Ramipril and resveratrol co-treatment attenuates RhoA/ROCK pathway-regulated early-stage diabetic nephropathy-associated glomerulosclerosis in streptozotocin-induced diabetic rats[J].Environ Toxicol,2019,34(7):861-868. [8] Yu C, Xiong C, Tang J, et al.Histone demethylase JMJD3 protects against renal fibrosis by suppressing TGF-β and Notch signaling and preserving PTEN expression[J]. Theranostics,2021,11(6):2706-2721. [9] Chen J, Shi W, Xu Y, et al.Hirudin prevents vascular endothelial cell apoptosis and permeability enhancement induced by the serum from rat with chronic renal failure through inhibiting RhoA/ROCK signaling pathway[J].Drug Dev Res,2021,82(4):553-561. [10] Matsushita K, Toyoda T, Yamada T, et al.Specific expression of survivin, SOX9, and CD44 in renal tubules in adaptive and maladaptive repair processes after acute kidney injury in rats[J]. J Appl Toxicol,2021,41(4):607-617.
